Loading...
POLX logo

Polarean Imaging Community

AIM:POLX Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

Community Investing Ideas

POLX logo
Polarean Imaging

Pharma Trials And Pediatric FDA Approval Will Open Global Markets

Key Takeaways New revenue vertical in pharma-sponsored trials and FDA approval for younger patients expand market opportunities and potential revenue streams. Successful reimbursement pathway and international expansion indicate future growth and reduced financial risk.Read more

View narrative
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
UK£0.04
96.3% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
94.04% p.a.
Profit Margin
8.43%
Future PE
46.63x
Share price in 2028
UK£0.037